MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Personalis Long Term Debt Current 2011-2026 | PSNL
Annual Long Term Debt Current Personalis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.89 M | 7.7 M | 7.76 M | 5.39 M | 3.73 M | 2.44 M | 1.36 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.76 M | 1.36 M | 5.04 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
54 K | $ 92.59 | 5.9 % | $ 4.33 B | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
662 K | $ 4.5 | -10.89 % | $ 5.99 M | USA |
 |
Fulgent Genetics
FLGT
|
1.46 M | $ 18.5 | 1.04 % | $ 569 M | USA |
 |
Castle Biosciences
CSTL
|
1.32 M | $ 21.08 | 4.77 % | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
535 K | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
36.3 M | $ 151.82 | -0.28 % | $ 11.9 B |  Irlanda |
 |
Illumina
ILMN
|
78 M | $ 160.03 | 1.26 % | $ 24.8 B | USA |
 |
Guardant Health
GH
|
27.7 M | $ 130.12 | 4.19 % | $ 16.3 B | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 22.75 | 3.64 % | $ 1.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
431 K | $ 1.74 | 3.57 % | $ 7.7 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
209 K | - | - | $ 7.1 B |  Australia |
 |
NeoGenomics
NEO
|
4.78 M | $ 11.44 | 4.47 % | $ 1.47 B | USA |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
451 K | $ 19.75 | 2.17 % | $ 442 M | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 99.98 | -0.03 % | $ 6.75 B | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 189.85 | 1.83 % | $ 9.41 B | USA |
 |
Pacific Biosciences of California
PACB
|
448 K | $ 1.37 | -0.72 % | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 466.79 | 1.94 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 162.79 | 2.1 % | $ 24 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 4.54 | 3.42 % | $ 420 M | USA |
 |
Natera
NTRA
|
15.6 M | $ 222.82 | 4.38 % | $ 30.5 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 26.5 | 2.63 % | $ 25.1 B |  Niderland |
 |
Senseonics Holdings
SENS
|
496 K | $ 7.43 | 4.21 % | $ 310 M | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
726 K | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.05 | -0.92 % | $ 4.71 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 271.24 | 3.52 % | $ 22.6 B | USA |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 70.06 | 0.03 % | $ 4.19 B | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 494.07 | 5.23 % | $ 186 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.29 | 2.43 % | $ 2.01 B | USA |
 |
Waters Corporation
WAT
|
31.1 M | $ 371.15 | 2.15 % | $ 22.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 204.53 | 3.71 % | $ 22.7 B | USA |